The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     
6 pts

Opinion on  SanofiAventis (SNY)     Sector: Healthcare  >  Industry: Biotechnology & Drugs
SNY is a buy

Jun 22, 2007 05:52 PM GMT
Return Risk
-29.21% HIGH
Analyst

If SNY's cash flow just continues "as is" this company is worth almost twice the current price of about $40.

Hammered by the Accomplia news but is it really bad enough news to keep this company from continuing its current cash flow? No, SNY will be putting all that cash flow to work and growing.

The current price is about 10% cheaper than where Buffett last bought in (but before the Accomplia news)

What's the downside? I can't think there is much room to go down. if there is, I'm buying more.


SNY:  This call was made on 06/22/07 @ $40.45
Rating:   Positive   $40.45 (06/22/07)
Gain/Loss:   -6.28% in 871 days
Target:   $47.00 (+16.19%) in > one year


Add Comment

Be the first to comment on this story and earn 2 points.

Your Comment



ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 noshoes 21.10 +35.23% 368
2 Gerald Greene 18.14 +70.19% 206
3 stockmarketfunding.com 17.66 +25.78% 53
4 akiralegrand 13.47 +14.32% 61
5 anup2104 12.13 +69.23% 34


POPULAR STOCKS
Symbol Company Name Sentiment
INTC Intel Corp
RIO Companhia Vale Do Rio Doce
PG The Procter & Gamble Company
JNJ Johnson & Johnson
MO Altria Group Inc
EBAY eBay Inc

TODAY'S HEADLINES

TODAY'S TOP PICKS

 
SanofiAventis (SNY)
   SocialPicks Sentiment:   

   This Quarter's Sentiment:
All:
81.0%
Top:
100.0%




Latest Picks by colindelia
Symbol SP Sentiment Rating Return Since
KG Positive -32.55% 07/30/07
XEC Positive +16.71% 07/12/07
TCK Positive -24.20% 07/03/07
CRYP Positive -82.91% 07/02/07
PFE Positive -31.59% 06/22/07

View All >
   




IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch